Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
26.84
+0.81 (3.11%)
At close: May 12, 2025, 4:00 PM
28.18
+1.34 (4.99%)
After-hours: May 12, 2025, 7:15 PM EDT
KNSA Employees
Kiniksa Pharmaceuticals International, had 315 employees as of December 31, 2024. The number of employees increased by 18 or 6.06% compared to the previous year.
Employees
315
Change (1Y)
18
Growth (1Y)
6.06%
Revenue / Employee
$1,527,511
Profits / Employee
-$53,810
Market Cap
1.96B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
KNSA News
- 7 days ago - Kiniksa Pharmaceuticals: Making Steady Progress - Seeking Alpha
- 12 days ago - Kiniksa Pharmaceuticals Announces GRAMMY® Award-Winning Country Star, Carly Pearce, Joins the Life DisRPted™ Campaign, Adding to Voices Advocating for Awareness of Recurrent Pericarditis - GlobeNewsWire
- 13 days ago - Kiniksa Pharmaceuticals International, plc (KNSA) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 13 days ago - Kiniksa Pharmaceuticals Reports First Quarter 2025 Financial Results and Recent Portfolio Execution - GlobeNewsWire
- 18 days ago - Kiniksa Pharmaceuticals to Report First Quarter 2025 Financial Results on April 29, 2025 - GlobeNewsWire
- 2 months ago - Big Pipeline Updates From Kiniksa Pharmaceuticals - Seeking Alpha
- 2 months ago - Kiniksa Pharmaceuticals International, plc (KNSA) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Kiniksa Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Portfolio Execution - GlobeNewsWire